No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Clinical Trials, Phase III as Topic
-
Everolimus
-
Humans
-
Indoles / therapeutic use
-
Neuroendocrine Tumors / classification*
-
Neuroendocrine Tumors / drug therapy
-
Neuroendocrine Tumors / pathology
-
Pancreatic Neoplasms / classification*
-
Pancreatic Neoplasms / drug therapy
-
Pancreatic Neoplasms / pathology
-
Pyrroles / therapeutic use
-
Randomized Controlled Trials as Topic
-
Sirolimus / analogs & derivatives
-
Sirolimus / therapeutic use
-
Sunitinib
-
World Health Organization*
Substances
-
Antineoplastic Agents
-
Indoles
-
Pyrroles
-
Everolimus
-
Sunitinib
-
Sirolimus